Pharmaceutical Industry Blog

Last Updated: July 19, 2026 TL;DR: Ghana — a West African healthcare market served by a four-tier public network of teaching hospitals (Korle Bu, Komfo Anokye and Tamale), regional hospitals, district hospitals and CHPS compounds, financed in large part through the National Health Insurance Scheme — carries a dual disease burden of malaria, tuberculosis, cholera and diarrhoeal illness alongside non-communicable diseases that now account for an estimated 43% of deaths, and tha

Last Updated: July 19, 2026 TL;DR: Uzbekistan — Central Asia's most populous country, served by a Ministry of Health network that runs from republican specialised scientific-practical medical centres in Tashkent through regional (viloyat) multidisciplinary medical centres to district hospitals and rural physician points — imports more than 80% of the medicines its patients use, which puts a permanent premium on reliable, compliant sterile injectable supply. Every medicine pla

Last Updated: July 18, 2026 TL;DR: Mozambique — a nation of around 35 million people whose predominantly public health system reaches from central hospitals in Maputo, Beira, Nampula and Quelimane down to provincial and district hospitals and a wide network of health centres, and which imports the large majority of its finished medicines and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of sterile injectables. Every imported ste

Last Updated: July 18, 2026 TL;DR: Ukraine — one of Europe's largest countries by area, home to tens of millions of people and served by a Ministry of Health system that runs from national specialist institutes and oblast (regional) hospitals in Kyiv, Lviv, Dnipro, Kharkiv and Odesa down to city, rayon and community hospitals and a reformed primary-care network — depends on a reliable, compliant supply of sterile injectables, with demand weighted heavily toward emergency, tra

Last Updated: July 18, 2026 TL;DR: Morocco — a nation of more than 38 million people with one of Africa's most developed health systems and its second-largest pharmaceutical industry, running from the CHU university hospitals in Rabat, Casablanca, Fez, Oujda, Marrakech and Tangier down to regional and provincial hospitals and a growing primary-care network under a universal health-insurance scheme (AMO) that now covers most of the population — depends on a reliable, compliant

Last Updated: July 18, 2026 TL;DR: Angola — a nation of more than 39 million people whose public-sector-led health system reaches from national and central hospitals in Luanda down to provincial hospitals in Huambo, Benguela, Lubango, Cabinda and Malanje and a wide network of municipal hospitals and health centres, and which imports the large majority of its finished medicines and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of